Second Actos Trial Begins

Lawyers for the family of Diep An told a Baltimore jury that drug giant Takeda’s failure to tell the whole truth about Actos role in the increased risk of cancer was the cause of death, as opening statements got under way. This case will provide further insight into how a jury views Takeda’s role in [...]

September 4th, 2013|Actos Diabetes Drug, Drug and Medical Device Litigation|Comments Off on Second Actos Trial Begins

Takeda’s Future after Losing Actos Patent

In 2012, Takeda’s profit dropped 53% and net profit was down 14% in the last nine months of 2012. Why? Because medical studies have demonstrated the causal connection between Takeda’s flagship diabetes drug Actos and bladder cancer and Takeda also lost its exclusivity patent on its foundation product diabetes treatment.  Actos accounted for more than [...]

August 26th, 2013|Actos Diabetes Drug, Drug and Medical Device Litigation|Comments Off on Takeda’s Future after Losing Actos Patent